HBW Executive Decisions: HPCUS Service Award For Land; Supplement VP New At CHPA; ACI Adds Microbiology Director; ABC Awards; More
Executive Summary
Mark Land receives HPCUS “Service to Homeopathy Award”; CHPA appoints John Troup to new post of dietary supplements executive; P&G’s Paul Gama elected CHPA board chair; FDA fellow, microbiology expert Queen joins ACI; more executive hires in consumer health and beauty sectors.
You may also be interested in...
CHPA Rebranding Reflects Growing Device Interests In Evolving Self-Care Market
The Consumer Healthcare Products Association’s rebranding initiative – its first in 20 years – aligns the group with today’s self-care marketplace where consumer medical devices play an increasingly prominent role. It also follows “landmark legislative achievements in 2020 that will further empower consumers to practice responsible self-care,” CHPA says.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.